Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease
John A Marwick1, Kian Fan Chung21Medical Research Council Centre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh Medical School, Edinburgh, UK; 2Section of Airways Disease, National Heart and Lung Institute, Imperial College London, UKAbstract...
Main Authors: | John A Marwick, Kian Fan Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-09-01
|
Series: | International Journal of COPD |
Online Access: | http://www.dovepress.com/glucocorticoid-insensitivity-as-a-future-target-of-therapy-for-chronic-a5171 |
Similar Items
-
T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease
by: Kaur Manminder, et al.
Published: (2012-03-01) -
Targeted therapy in eosinophilic chronic obstructive pulmonary disease
by: Mathieu Fieldes, et al.
Published: (2021-04-01) -
The Effect of Glucocorticoids on Bone Mass in Patients with Asthma and Chronic obstructive Pulmonary Disease
by: Evrim Karadağ Saygı, et al.
Published: (2005-06-01) -
Anti-inflammatory therapy in chronic obstructive pulmonary disease: present and future
by: S. N. Avdeev
Published: (2013-12-01) -
Models of chronic obstructive pulmonary disease
by: Chung K Fan, et al.
Published: (2004-11-01)